Taoyuan, Taiwan

Chih-Wei Fu

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chih-Wei Fu: Innovator in Pharmaceutical Chemistry

Introduction

Chih-Wei Fu is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds with therapeutic applications. With a total of 2 patents to his name, Fu's work is recognized for its potential impact on medical science.

Latest Patents

Chih-Wei Fu's latest patents include an androgen receptor binding molecule and a beta-amino acid derivative that serves as a kinase inhibitor. The androgen receptor binding molecule features a complex structure that allows for specific interactions with androgen receptors, which are crucial in various biological processes. The beta-amino acid derivative is designed to inhibit kinase activity, providing a pharmaceutical composition that can be utilized in various in vivo applications.

Career Highlights

Fu is affiliated with the Industrial Technology Research Institute, where he engages in cutting-edge research and development. His work focuses on creating novel compounds that can lead to advancements in therapeutic treatments. His innovative approach and dedication to research have positioned him as a key figure in his field.

Collaborations

Chih-Wei Fu collaborates with talented individuals such as Chiu-Lien Hung and Hao-Hsuan Liu. These partnerships enhance the research environment and foster the development of groundbreaking inventions.

Conclusion

Chih-Wei Fu's contributions to pharmaceutical chemistry through his patents and research at the Industrial Technology Research Institute highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…